Gema Diagnostics
Gema Diagnostics: A Michigan-based molecular diagnostics firm specializing in assisted reproductive technology.
Founded
2005Gema Diagnostics: A Michigan-based molecular diagnostics firm specializing in assisted reproductive technology.
Gema Diagnostics, founded in East Lansing, Michigan, is a molecular diagnostics company specializing in assisted reproductive technology. The company's core mission is to enhance the success rates of in vitro fertilization (IVF) through advanced diagnostic tools. Gema Diagnostics offers innovative molecular diagnostic products designed to improve embryo selection and overall IVF outcomes, focusing on providing cutting-edge solutions for fertility clinics and patients.
Notable figures affiliated with Gema Diagnostics include experts in molecular biology and reproductive medicine. The company has garnered attention from investors interested in advancing reproductive health technologies. Key achievements include the development of proprietary diagnostic methods that have shown promise in clinical settings, contributing to higher IVF success rates. Gema Diagnostics' impact lies in its potential to transform the landscape of assisted reproductive technology, offering hope and improved outcomes for individuals and couples seeking fertility treatments.
Companies similar to Gema Diagnostics include Ovagene Oncology, Iverson Genetic Diagnostics, Genassist and Empowered Diagnostics.
Gema Diagnostics was founded in 2005.
Gema Diagnostics' headquarters is located in Ann Arbor, MI, US.
Gema Diagnostics' most recent funding round was for $625k (USD) in April 2013.
As of Apr 8, 2013, Gema Diagnostics has disclosed funding of $3.3M (USD). Undisclosed round amounts are excluded.
Gema Diagnostics has 5 employees as of Feb 5, 2024.
Empowered Diagnostics
